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consistent with the PD pathology classification of Braak. The 
initial anterior temporal atrophy with spread to occipitotem-
poral and posterior parietal regions may subserve ‘emotion-
based’ sensorimotor transformations and deficits in the vi-
sual domain, respectively, which may be regarded as premo-
tor symptoms.  © 2014 S. Karger AG, Basel 
 Introduction 
 The main pathology in idiopathic Parkinson’s disease 
(PD) is degeneration of the substantia nigra and its do-
paminergic projections to the striatum  [1] , which is a 
major cause of the motor symptoms in this disease. This 
is associated with misfolding of α-synuclein  [2] . It is in-
creasingly recognized, however, that PD not only in-
volves the motor system, but inflicts deterioration in 
multiple domains. For instance, olfactory dysfunction is 
considered as a relatively early or even preclinical sign in 
PD  [3] , while in later stages pathological changes in ol-
faction-related brain areas have been described  [4] . Cor-
tical atrophy has been demonstrated to correlate with 
olfactory dysfunction in PD  [5] . Especially in later stages, 
cognitive impairment, including visuospatial dysfunc-
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 Abstract 
 Background: Parkinson’s disease (PD) is characterized by 
specific motor and nonmotor impairments. This suggests 
that PD is characterized by disease-specific regional cortical 
atrophy. Given the change of symptoms over time, a concur-
rent increase in regional atrophy may further be assumed to 
reflect the dynamic process of disease progression.  Meth-
ods: In this study we retrospectively collected T1-weighted 
MRI scans from previous studies performed in our center, en-
abling the comparison of gray matter atrophy in 77 PD pa-
tients with 87 controls using voxel-based morphometry 
(VBM). This large VBM analysis provided the opportunity to 
investigate cortical atrophy in relation with disease progres-
sion.  Results: We found significant PD-related reductions of 
gray matter density bilaterally in the anterior temporal cor-
tex, the left inferior frontal and left extrastriate visual cortex, 
independent from normal aging. The anterior temporal cor-
tex did not show major progression, whereas particularly the 
posterior parts of the lateral temporal cortex and adjacent 
extrastriate visual cortex occurred at a later stage of disease. 
 Conclusions: Temporal pole atrophy as an early sign of PD is 
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tion and alterations in executive functions, occurs rela-
tively often in PD  [6] . Such cortical dysfunction suggests 
that PD is characterized by a disease-specific regional 
atrophy. Given the change of symptoms over time, an 
associated change in the distribution of regional atrophy 
may further be assumed to reflect the dynamic process 
of disease progression. In a network view of the brain, it 
is reasonable to think that initial subcortical damage in 
PD may inflict cortical impairments in regions that re-
ceive projections from such subcortical sources  [7] . One 
may thus hypothesize that long-term hypoactivation of 
the cortex by subcortical structures leads to cortical at-
rophy.
 Voxel-based morphometry (VBM) studies in PD typi-
cally comprised small subject groups and yielded variable 
and even conflicting results  [8] . In the present study, we 
retrospectively collected 3-tesla MRI images of 77 PD pa-
tients that were included in previous studies performed 
at our center. This resulted in one of the largest VBM 
analyses comparing patients with PD and controls. Given 
the variation in disease duration of these patients, it also 
provided the opportunity to investigate cortical atrophy 
as an index of disease progression.
 Methods 
 Subjects 
 T1-weighted images were retrospectively collected from all 7 
studies performed in our center between 2007 and 2013 (104 con-
trols, 111 PD patients). These studies concerned only 1 VBM 
study  [9] and 6 different functional MRI experiments that includ-
ed the acquisition of a T1-weighted anatomical brain image used 
for coregistration and the assessment of general brain character-
istics. Since some subjects participated in more than 1 study, we 
only used the last scan made in order to assess the patient scans 
with the most pronounced characteristics of disease. As 34 PD 
patients and 8 controls participated in 2 or more studies, the con-
trol scans outnumbered the included PD scans. This provided the 
opportunity to make a selection of control subjects in order to get 
an optimally age-matched control group. To that end, we inspect-
ed the age distribution of both groups, after excluding the first of 
the possible double scans, and subsequently excluded 9 controls 
that were not in the same age group as the PD patients. This re-
sulted in a total of 87 controls and 77 patients with PD who were 
included for further analysis. Patients met the criteria of the UK 
PD Society Brain Bank. Severity of motor symptoms was assessed 
using part III of the Unified Parkinson’s Disease Rating Scale 
( UPDRS)  [10] . The Mini-Mental State Examination (MMSE) was 
used as a screening tool for cognitive functions. An MMSE  ≥ 24 
was considered to represent unimpaired cognition. Subjects suf-
fering from neurological disorders other than PD or psychiatric 
disorders were excluded. All studies were approved by the local 
Medical Ethical Committee. Participants gave their written in-
formed consent.
 Image Acquisition 
 Data acquisition was performed using a 3-tesla Philips MR sys-
tem (Best, the Netherlands) with a standard 8-channel SENSE 
head coil. In 3 of the 6 studies (49 controls, 45 PD patients) T1-
weighted 3-dimensional anatomical scans were acquired with field 
of view 232 × 256 × 170, TR = 9.0 ms, TE = 3.5 ms, flip angle 8°, 
170 slices without slice gap and voxel size 0.9 × 1 × 1 mm. The 
other 3 studies (38 controls, 32 PD patients) acquired T1-weighted 
scans with field of view 256 × 160 × 204 mm, TR = 25 ms, TE = 4.6 
ms, flip angle 30°, 160 slices with slice gap –1 and voxel size 1 × 1 × 
1 mm. The two acquisition protocols were equally distributed over 
the groups.
 Image Analysis 
 VBM is a method applied in MRI data sets, which offers the 
opportunity to compare the entire cortex across different groups 
without a priori assumptions on a subjective region of interest se-
lection  [11] . VBM enables the detection of differences in gray mat-
ter concentration on a local scale, while correcting for global shape 
differences  [11] . Image processing and voxel-based statistical anal-
ysis were conducted using Statistical Parametric Mapping, version 
8 (2009, Wellcome Department of Cognitive Neurology, London, 
UK; http://www.fil.ion.ucl.ac.uk/spm). Raw images were manu-
ally reoriented to put the middle of the anterior commissure at the 
coordinate x0.y0.z0 position. The images were processed using the 
unified segmentation approach with standard settings  [12] . In this 
approach the images are segmented in gray matter, white matter 
and cerebrospinal fluid, bias corrected and spatially normalized to 
the Montreal Neurological Institute brain reference space, based 
on nonlinear registration with tissue probability maps. The seg-
mented gray matter images were modulated and smoothed (full 
width at half maximum 8). We used the optimized VBM method 
in SPM8, because it is widely used and there is extensive experience 
with this method. An alternative might have been to use DARTEL. 
It has, however, been shown that DARTEL not necessarily results 
in better image registration in patients with Alzheimer’s disease, 
frontotemporal dementia and semantic dementia, while it may be 
less sensitive than the method we used  [13] . On the other hand, 
DARTEL has been reported to be more sensitive for detecting hip-
pocampal changes in acute depression  [14] .
 Statistical Analysis of Behavioral Parameters 
 MMSE scores and age were not normally distributed and there-
fore tested for differences between the groups with the Mann-
Whitney U test. Gender was compared using the χ 2 test. A p value 
<0.05 was considered statistically significant.
 Image Statistical Analysis 
 Total gray matter was calculated per subject and used as a co-
variate in the model to remove variance due to differences in brain 
size, because we were interested in regional gray matter differenc-
es. Also, the type of T1 scan was used as a covariate to correct for 
possible effects of differences in scanning parameters. Initial anal-
ysis assessed the presence of regional differences between patients 
and controls at voxel level p < 0.001 to see if there were any differ-
ences. Resulting clusters of regional difference were regarded sta-
tistically significant at p < 0.05 family-wise error (FWE) corrected 
with a cluster extent of 8 voxels. We compared healthy controls 
(n = 87) with PD patients (n = 77) on local gray matter density 
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er the perceived atrophy was not merely the consequence of nor-
mal aging we similarly compared the 25 youngest controls with the 
25 oldest controls. In addition, we compared the 87 healthy con-
trols with the 25 PD patients with the shortest duration of disease 
(PD_short) and the 25 patients with the longest disease duration 
(PD_long), respectively. These comparisons were expected to pro-
vide insight into disease progression. An additional comparison 
between the 25 PD_short and 25 PD_long patients complemented 
the two comparisons between patients and control subjects. The 
reason to introduce this binary split was to get a clear distinction 
between the subgroups with short and long disease duration, leav-
ing out patients with intermediate disease duration. The large pa-
tient group indeed allowed such a selection.
 Results 
 There were no significant differences between PD pa-
tients and healthy controls regarding age and gender, 
while the MMSE score was slightly but significantly low-
er in the patient group ( table 1 ). None of the participants 
had an MMSE below 24.
 VBM of Patients with PD versus Controls 
 Comparison of PD patients with healthy controls re-
vealed significant reductions of regional gray matter den-
sity which was most pronounced in anterior temporal re-
gions ( fig. 1 a;  table 2 ). Adjacent to the cluster of left ante-
rior temporal atrophy, inferior frontal atrophy was seen, 
while in the right hemisphere posterolateral frontal atro-
phy was seen at a more dorsal position. In posterior parts 
of the brain, cortical atrophy was identified in both ven-
trolateral and dorsal extrastriate visual areas of particu-
larly the left hemisphere, together with significant right 
precuneus atrophy. At a relaxed threshold of p < 0.001 
voxel level uncorrected, the revealed pattern of reduced 
right occipital and parietal gray matter density was simi-
lar to that in the left hemisphere. There were no regions 
identified with more gray matter atrophy in controls 
compared to PD patients.
 Progression of Cortical Atrophy in Patients with PD 
 Statistical analysis showed that disease duration of the 
25 PD_short patients (mean duration 3.3 years, SD 1.2) 
was indeed significantly shorter compared to the PD_
long patients (mean 13.2 years, SD 4.1; p < 0.001). These 
two groups did not differ in age and MMSE. Mean age of 
PD_short was 61.8 years (SD 8.8) with a mean MMSE of 
27.6 (SD 1.3) while it was 63.0 years (SD 7.1) for PD_long 
and MMSE 27.4 (SD 1.3) (p = 0.60 for each parameter). 
Neither did the two groups differ in gender (15 males in 
PD_short and 16 males in PD_short, p = 0.77). The groups 
had an equal distribution in the type of T1 scan (17 of the 
first sequence described in the Methods).
 Compared to the control group, the 25 PD_short pa-
tients had cortical atrophy of both temporal poles (p  < 
0.001, voxel level uncorrected;  fig. 1 b). This difference in 
gray matter density did, however, not reach statistical sig-
nificance at cluster level corrected for the entire brain vol-
ume (FWE). When the 25 PD_long patients were com-
pared with the controls, significant gray matter reductions 
were seen at the two temporal poles and in left extrastriate 
cortical regions (p < 0.05, FWE corrected;  fig. 1 c).
 Complementary to comparing the control subjects 
with successively the PD_short and PD_long patients, a 
direct comparison of PD_short with PD_long showed a 
progression of regional atrophy in the PD_long group at 
the lateral occipitotemporal junction, bilaterally, with a 
maximum in the right middle temporal gyrus (x 54, y –42, 
z –4; p < 0.001, voxel level uncorrected;  fig. 1 d;  table 3 ). 
No differences were seen at the temporal poles. The clus-
ters of advanced atrophy did, however, not reach signifi-
cance at the cluster level corrected for the entire brain 
volume. This was also the case for changes in the right 
middle frontal gyrus (BA 45) and right supramarginal gy-
rus (BA 2).
 Comparison of Old and Young Controls 
 In comparison with the 25 youngest controls (mean 
age 51.3 years, SD 4.3), the 25 oldest control subjects 
(mean age 68.1 years, SD 3.7) had a reduction of gray mat-
ter density in both the midcingulate cortex and superior 
surface of the left temporal lobe along the sylvian fissure 
(online suppl. fig.  1; for all online suppl. material, see 
www.karger.com/doi/10.1159/000363245). This differ-






Age, years 60.1 (7.2) 87 63.0 (10.5) 77 0.07
Gender, male 50 851 46 701 0.42
MMSE (0–30) 28.0 (1.0) 841 27.0 (1.3)2 701 0.00
UPDRS III (0–56) n.a. n.a. 24.3 (7.5) 691 n.a.
Disease duration,
years n.a. n.a. 8.0 (5.1) 651 n.a.
 Data presented as means with standard deviation in parenthe-
ses. n.a. = Not applicable.
1 Lower subject number due to missing data.
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ence in gray matter density only reached a subthreshold 
significance level of p < 0.001 (voxel level, uncorrected) 
while the difference in age was indeed statistically signif-
icant (p < 0.01).
 Discussion 
 In this large study with 77 PD patients, we found sig-
nificant PD-related reductions of gray matter density in 
predominantly the anterior temporal cortex, bilaterally, 
left inferior frontal and left extrastriate visual cortex. 
This distribution of regional atrophy was different from 
the observed aging-associated pattern of atrophy in tem-
poral perisylvian and cingulate cortices. The latter was 
consistent with previous studies on normal aging  [15] . 
Progression of atrophy in PD was inferred from the 
comparison between patients with the shortest and lon-
gest disease durations. This analysis indicated that the 
early anterior temporal atrophy did not show major pro-
gression, whereas atrophy of particularly the posterior 
parts of the lateral temporal cortex and adjacent ex-
 Fig. 1.  a Clusters of significant regional reduction of gray matter 
density in patients with PD when compared to control subjects 
(p < 0.05, FWE corrected, voxel extent k of 8 voxels). In addition 
to the brain volume images, the atrophy at the ventral surface of 
the temporal poles is depicted on a coronal slice at y +2 mm rela-
tive to the vertical traversing the anterior commissure.  b The single 
regions with reduction of gray matter density in the 25 patients 
with PD with the shortest disease duration compared to the 87 
healthy control subjects (p < 0.001, uncorrected, k of 8 voxels) in 
a coronal section (y +2 mm).  c Regional reduction of gray matter 
density in the 25 PD patients with the longest disease duration 
compared to healthy controls (p < 0.05, FWE corrected, k of 8 vox-
els).  d Regional reduction of gray matter density of the 25 PD pa-
tients with the longest disease duration when compared to the 25 
patients with the shortest disease duration (voxel level p < 0.001, 
uncorrected, k of 20 voxels). In addition, the atrophy of the right 
fusiform gyrus, right middle temporal gyrus and left inferior tem-
poral gyrus are depicted on a coronal slice at y –44 mm relative to 
the vertical traversing the anterior commissure. Clusters are ren-
dered onto the volume or a section of a standard T1-weighted 
brain (Montreal Neurological Institute). t values are indicated by 
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trastriate visual cortex occurred at a later stage of dis-
ease, together with reductions of gray matter density in 
the right supramarginal and right inferior frontal gyrus. 
Temporal pole atrophy as an early sign of PD would 
seem consistent with the previous description of Braak 
et al.  [4] .
 Anterior Temporal Atrophy 
 At first sight, atrophy at the temporal pole may seem 
at odds with the dominant characteristics of motor dys-
function, which define PD. On the other hand, the con-
sistency of symptoms such as hyposmia that precede 
motor symptoms may point at an impaired function of 
 Table 3.  Progression of cerebral gray matter loss in PD (PD_short > PD_long)
Brain region x y z t value Extent p uncorrected
Right hemisphere
Middle temporal gyrus (BA 21) 54 –42 –4 3.9 56 0.24
Fusiform gyrus (BA 19) 36 –40 –20 4.3 82 0.16
Supramarginal gyrus (BA 2) 62 –26 46 3.7 40 0.32
Middle frontal gyrus (BA 45) 60 32 16 3.8 64 0.21
Left hemisphere
Inferior temporal gyrus –54 –46 –14 3.5 32 0.38
Inferior temporal gyrus –54 –58 –4 3.5 75 0.18
Middle temporal gyrus (BA 21) –56 –56 20 3.3 21 0.48
Extrastriate visual cortex (BA 19) –54 –72 4 3.5 28 0.41
 Coordinates (standard brain Montreal Neurological Institute, MNI) refer to voxels of maximal difference 
in clusters surviving a threshold of p < 0.001 uncorrected with a voxel extent of 20 voxels. BA = Brodmann 
area.
 Table 2.  Regional decreases in cerebral gray matter in patients with PD compared with controls
Brain region x y z t value Extent p corrected
Right hemisphere
Temporal pole (BA 38) 32 14 –28 6.65 979 0.000
Inferior temporal gyrus (BA 20) 50 4 –42 6.52 s.c. s.c.
Fusiform gyrus (BA 19) 26 –70 –14 5.47 18 0.012
Superior parietal lobule (BA 7) 8 –68 58 5.34 22 0.009
Rolandic operculum (BA 48) 46 –4 10 5.26 9 0.020
Dorsolateral prefrontal cortex (BA 46) 52 16 36 5.48 15 0.014
Left hemisphere
Temporal pole (BA 38) –30 18 –32 5.40 253 0.000
Inferior frontal gyrus (BA 47) –44 20 –2 5.39 s.c. s.c.
Inferior temporal gyrus (BA 20) –56 –6 –34 5.46 260 0.000
Hippocampus (BA 27) –24 –10 –12 5.49 75 0.001
Fusiform gyrus (BA 19) –28 –74 –16 5.78 81 0.001
Anterior lingual gyrus (BA 27) –12 –36 –6 5.74 36 0.005
Extrastriate visual cortex (BA 19) –50 –76 0 6.12 221 0.000
Superior occipital gyrus (BA 18) –24 –92 26 5.44 49 0.003
Cuneus (BA 18) –2 –84 34 5.21 31 0.006
 Coordinates (standard brain Montreal Neurological Insititute) refer to the voxels of maximum difference 
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the anterior (anteromedial) aspects of the temporal 
lobes  [3, 5] . Moreover, assessments of postmortem pa-
thology in PD have indicated that, following intraneu-
ronal brainstem pathology, initial cortical involvement 
particularly concerns the anteromedial temporal cortex 
 [4] . Although particularly medial temporal atrophy in 
PD may hint at cognitive impairment  [16] , it has also 
been well documented for PD patients without signs of 
dementia  [17] . It was intriguing to see that the most pro-
nounced atrophy was found at the temporal pole, while 
progression of atrophy was not significantly present at 
this location. This may suggest that such a progression 
slows down in the course of disease. At an early disease 
stage, degeneration in particularly this region has in-
deed been shown by Braak et al.  [4] . This might thus 
imply that due to advanced atrophy, additional progres-
sion is slower.
 VBM examination of MR images for regional atro-
phy in PD patients, compared to healthy controls, has 
shown marked heterogeneity in the reported regions of 
atrophy, while some studies even failed to find any at-
rophy  [18, 19] . Relatively small study groups and differ-
ences in analysis methods are possible reasons for this 
variation. A common finding, nevertheless, appears to 
be atrophy of the temporal lobes, particularly in limbic 
and paralimbic regions  [8] . However, with deforma-
tion-based morphometry there was only a significant 
contraction in the left cerebellum in early PD  [20] . In a 
meta-analysis on clusters with significant gray matter 
reduction in PD obtained from 17 VBM studies involv-
ing 498 patients, Pan et al.  [8] identified a single region 
of gray matter reduction comprising the left inferior 
frontal gyrus, anterior insula and left superior temporal 
gyrus  [ for a review in a broader perspective than VBM, 
see  21] . This focus of regional atrophy exactly corre-
sponds to our main left-hemisphere cluster, while we 
found additional atrophy of the same region in the oth-
er hemisphere. Patient characteristics reported in the 
meta-analysis of Pan et al. [8] (mean age 66 years, dis-
ease duration 6.9 years and UPDRS III 24.1) indicated 
that our study represented an average PD population 
(mean age 63.0 years, disease duration 8.0 years and 
UPDRS III 24.3). Moreover, the variation in disease du-
ration in our patient group with a mean of 3.3 years and 
13.3 years for PD_short and PD_long, respectively, 
made it feasible to additionally examine the pattern of 
atrophy progression. The coherence of results from di-
rectly comparing PD_short with PD_long and from the 
comparison of controls with each of these PD subgroups 
laid ground for the conclusion that the initial anterior 
temporal atrophy particularly spread to occipitotempo-
ral and posterior parietal regions. 
 The temporal pole is implicated in a wide range of 
functions, particularly characterized by the attribution of 
an emotional content to stimuli in various perceptual do-
mains  [22] . Such emotion-related processing not only 
concerns its perception, but is intrinsically related to 
emotional expression, including simple vegetative re-
sponses such as changed heart rate or releasing tears, as 
well as more complex motor behavior  [23, 24] . In this 
respect, functional coherence between limbic system 
structures such as anteromedial temporal regions, adja-
cent insula, orbitofrontal cortex and ventral striatum is 
logically subserving ‘emotion-based’ sensorimotor 
transformations  [23] . The amygdala complex, embedded 
anteromedially in the temporal lobe, seems to play an 
important role in the integration of internal emotional 
states and actual stimulus conditions in guiding e.g. the 
ventral striatum in the onset of behavioral responses  [23, 
25] . A functional consequence of coherent temporal-
striatum involvement in such circuitry is that its dys-
function, associated with temporal pole atrophy, may 
not only lead to olfactory deficit, but also to PD premotor 
symptoms such as depression, anxiety and autonomic 
impairment  [26] . In this respect, a typical PD symptom 
such as hypomimia may not only be regarded as a mani-
festation of motor dysfunction, but may well reflect a 
more complex impairment of emotional processing, in-
cluding emotion-motor transformation. The role of the 
temporal pole in emotion perception has been well de-
scribed  [22] . For instance, it supports our empathizing 
with other people  [27] , while bilateral removal of the 
temporal poles in monkeys leads to a disturbance in rec-
ognizing, interpreting and reacting to social signals  [28] .
 It is intriguing to notice that the left-lateralized fron-
totemporal atrophy in the referred meta-analysis of Pan 
et al.  [8] fits the observation that PD-related deficit in the 
uncinate fascicle particularly occurred in the left hemi-
sphere  [29] . Although Kim et al.  [29] described more 
widely distributed white matter changes in the PD brain, 
changes in the crucial connection between the temporal 
pole and orbitofrontal cortex underscore the anterior 
temporal involvement in PD pathology. 
 A biochemical relation between anteromedial temporal 
dysfunction and PD might be inferred from the dopamine 
innervation in normal human subjects, as revealed by  18 F-
DOPA positron emission tomography. While striatum 
uptake of this tracer is the most evident feature of this func-
tional imaging method,  18 F-DOPA uptake in limbic struc-
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than 4 times higher than that of the neocortex of the oc-
cipital lobe  [30] . This implies that impaired dopamine in-
nervation from the upper brainstem may have a larger im-
pact on the referred limbic than neocortical regions. This 
argument, however, was not supported by the assessment 
of extrastriatal uptake of this tracer, as limbic uptake was 
not specifically reduced in early PD stages  [31] . 
 Posterior Cortical Atrophy 
 In addition to anterior temporal atrophy, regional 
clusters of PD-related atrophy particularly comprised 
posterior temporal, extrastriate visual and posterior pari-
etal cortical regions. Moreover, the progression of atro-
phy during disease took place in predominantly these 
posterior regions, which suggests that it might initially 
follow the course of the inferior longitudinal fasciculus 
 [32] or, more stepwise, the functional ventral visual path-
way in reversed direction  [33] . Such a progression of at-
rophy towards posterior temporal and extrastriate visual 
cortical regions would be consistent with a specific PD-
related dysfunction in the visual domain. The latter in-
cludes hallucinations, which have been associated with 
impaired visual object processing in ventrolateral ex-
trastriate visual areas  [34] . The posterior parietal progres-
sion seems consistent with an important profile of neuro-
psychological dysfunction seen early in the course of the 
disease, which may predict cognitive decline  [35] . The as-
sociation between functional impairment of both visual 
and parietal cortex regions in PD  [36] and observations 
that visual stimuli may have a stronger impact on gait 
control in this disease  [37, 38] underscore that more 
knowledge on visual cortex changes is required for un-
derstanding distinct PD symptoms.
 Atrophy in Motor-Related Areas 
 While prefrontal and parietal foci of atrophy 
were found in our study, it may seem quite remarkable 
that no atrophy was seen in the striatum and cortical 
regions more specifically involved in motor processing. 
In a network view of cerebral processing, one might log-
ically expect that degeneration of a crucial node or hub, 
such as the substantia nigra pars compacta, would in-
flict changes in distant parts of such a network (e.g. the 
cortico/basal ganglia/thalamocortical loops). This view 
is supported by the distribution of decreased metabo-
lism including the premotor cortex in patients with PD 
 [36] . One may, in this respect, speculate that atrophy in 
these regions may occur at more advanced stages of PD 
following a preceding decrease in metabolism.
 Conclusion 
 VBM in a large group of PD patients showed that cor-
tical atrophy was most pronounced at the temporal poles 
and the occipitotemporal junction, while it spread toward 
the lateral temporal cortex and adjacent extrastriate cor-
tex in advanced PD. This distribution of cortical pathol-
ogy highlights the presence of ‘premotor’ symptoms in 
PD. 
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